Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 16:16:3775-3783.
doi: 10.2147/OPTH.S379373. eCollection 2022.

Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions

Affiliations

Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions

Ana Filipa Moleiro et al. Clin Ophthalmol. .

Abstract

Purpose: This work aimed to longitudinally assess the peripapillary (PPCT) and subfoveal (SFCT) choroidal thickness (CT), in patients diagnosed with central (CRVO) or branch retinal vein occlusions (BRVO), correlating SFCT with central macular thickness (CMT) and PPCT with peripapillary retinal nerve fiber layer thickness (pRNFL).

Patients and methods: This was a retrospective longitudinal study of 71 eyes from 71 patients with treatment-naïve retinal vein occlusion (24 CRVO and 40 BRVO). Spectral-domain optical coherence tomography (SD-OCT, Spectralis HRA-OCT, Heidelberg) was used to measure PPCT, SFCT, pRNFL and CMT of the affected and fellow eyes at baseline (acute phase) and at 3 and 9 months post anti-VEGF treatment. IBM SPSS Statistics version 27.0 (IBM Corp., Armonk, NY, USA) was used for statistical analysis. A p-value ≤0.05 was considered statistically significant.

Results: Affected eyes presented a thicker baseline PPCT and SFCT compared to their fellow eyes both in CRVO and BRVO (p < 0.05). Both groups presented a significant decrease of PPCT in the affected eyes at 3 months compared to baseline (p < 0.05). At 9 months, compared to 3 months, PPCT remained stable (p > 0.05). Similarly, affected eyes' SFCT significantly decreased at 3 months (p < 0.05) in both groups. At 9 months, compared to 3 months, SFCT decreased in the CRVO patients (p = 0.047) but remained stable in the BRVO patients (p = 0.850). No correIations between SFCT and CMT were seen at any timepoint in both groups (p > 0.05). PPCT correlates with pRNFL in CRVO at 3 months, although no other correlations were found during the follow-up. In BRVO, PPCT did not show any significant correlation with pRNFL.

Conclusion: Both in CRVO and BRVO eyes, PPCT and SFCT at diagnosis are significantly thicker compared to the fellow eye, suggesting a possible increase in CT immediately after the occlusion, which is followed by a decrease at an early follow-up stage.

Keywords: biomarkers; choroidal thickness; optical coherence tomography; retinal vein occlusions; vascular retinal diseases.

PubMed Disclaimer

Conflict of interest statement

Dr Susana Penas reports personal fees from Alimera, Bayer, Novartis, and Roche, outside the submitted work. The author reports no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Schematic representation of macular choroidal thickness measurement. Choroidal Thickness was measured from the outer edge of the hyperreflective line, corresponding to the Retinal Pigment Epithelium, to the choroidal-scleral junction. Measurements were taken at the subfoveal level (yellow caliper).
Figure 2
Figure 2
Measurement illustration of peripapillary choroidal thickness at 4 locations. Manual delineation of the inner (top red line) and outer choroidal (bottom red line) borders using eye-tracking software (Heidelberg Engineering). Measurement of choroidal thickness at 4 locations using image-processing software, illustrated with the green vertical lines. (A) Temporal choroidal thickness measurement; (B) Nasal choroidal thickness measurement; (C) Superior choroidal thickness measurement; (D) Inferior choroidal thickness measurement.

References

    1. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133–141. - PMC - PubMed
    1. Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117(2):313–9.e1. doi:10.1016/j.ophtha.2009.07.017 - DOI - PMC - PubMed
    1. Laouri M, Chen E, Looman M, Gallagher M. The burden of disease of retinal vein occlusion: review of the literature. Eye. 2011;25(8):981–988. doi:10.1038/eye.2011.92 - DOI - PMC - PubMed
    1. Martínez F, Furió E, Fabiá MJ, et al. Risk factors associated with retinal vein occlusion. Int J Clin Pract. 2014;68(7):871–881. doi:10.1111/ijcp.12390 - DOI - PubMed
    1. Fong AC, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol. 1993;37(6):393–417. doi:10.1016/0039-6257(93)90138-W - DOI - PubMed

LinkOut - more resources